Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now official registry

Sudden Cardiac Death clinical trials

5 of 10 indexed Sudden Cardiac Death trials are currently recruiting.

10 US clinical trials · 5 currently recruiting

Sudden Cardiac Death is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Abbott Medical Devices, running 2 of these trials.

The research picture

Sudden Cardiac Death has 10 registered US clinical trials, 5 of them open to new participants right now, about 50% of the total.

5
recruiting participants now
50%
of trials open to enrollment
3
in Phase 3–4 (later-stage)
2
top sponsor: Abbott Medical Devices
Phase 43

Active & Recent Trials

10 total, page 1 of 1

RECRUITING Phase 4 2,000 participants

Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

University of Rochester

NCT06964464

RECRUITING NA 1,058 participants

Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD)

Western Sydney Local Health District

NCT03588286

RECRUITING 1,000 participants

Mayo AVC Registry and Biobank

Mayo Clinic

NCT03049254

RECRUITING 400 participants

Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk

Johns Hopkins University

NCT00181233

RECRUITING 135 participants

Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax

National Heart, Lung, and Blood Institute (NHLBI)

NCT05724121

ACTIVE NOT RECRUITING 5,764 participants

PRE-DETERMINE Cohort Study

Brigham and Women's Hospital

NCT01114269

COMPLETED 1,701 participants

SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients

Abbott Medical Devices

NCT00940888

COMPLETED 448 participants

Arrhythmias in Myotonic Muscular Dystrophy

Indiana University School of Medicine

NCT00622453

COMPLETED Phase 4 198 participants

Predictive Risk Stratification Through T Variability in ICD Patients Without Pacing Indications

LivaNova

NCT00560768

COMPLETED Phase 4 77 participants

'Effect of CRT on Defibrillation Threshold Estimates' Study

Abbott Medical Devices

NCT00626093

Phase Distribution

PhaseTrial count
Phase 4 3

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Sudden Cardiac Death Trial Landscape

10 indexed Sudden Cardiac Death studies · 5 recruiting (50%).

Phase mix: 3 late (III/IV) vs 0 early (I/II).

Top sponsor: Abbott Medical Devices (2 trials), 8 others listed. 10 shown below, recruiting first.

How to read this condition's trial landscape

That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation, eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Sudden Cardiac Death?

PlainTrial tracks 10 US clinical trials for Sudden Cardiac Death, of which 5 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Sudden Cardiac Death?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.